<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(6)</volume><submitter>Liu P</submitter><pubmed_abstract>We report herein the discovery of a fatty acid amide hydrolase (FAAH) positron emission tomography (PET) tracer. Starting from a pyrazole lead, medicinal chemistry efforts directed toward reducing lipophilicity led to the synthesis of a series of imidazole analogues. Compound 6 was chosen for further profiling due to its appropriate physical chemical properties and excellent FAAH inhibition potency across species. [(11)C]-6 (MK-3168) exhibited good brain uptake and FAAH-specific signal in rhesus monkeys and is a suitable PET tracer for imaging FAAH in the brain.</pubmed_abstract><journal>ACS medicinal chemistry letters</journal><pagination>509-13</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4027136</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase.</pubmed_title><pmcid>PMC4027136</pmcid><pubmed_authors>Riffel K</pubmed_authors><pubmed_authors>Williams M</pubmed_authors><pubmed_authors>Nargund RP</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Liu P</pubmed_authors><pubmed_authors>Williams D</pubmed_authors><pubmed_authors>Jochnowitz N</pubmed_authors><pubmed_authors>Fung S</pubmed_authors><pubmed_authors>Alexander J</pubmed_authors><pubmed_authors>Miller P</pubmed_authors><pubmed_authors>Abbadie C</pubmed_authors><pubmed_authors>Posavec D</pubmed_authors><pubmed_authors>DeVita RJ</pubmed_authors><pubmed_authors>Karanam B</pubmed_authors><pubmed_authors>Sanabria S</pubmed_authors><pubmed_authors>Jin H</pubmed_authors><pubmed_authors>Salituro G</pubmed_authors><pubmed_authors>Powell J</pubmed_authors><pubmed_authors>Hamill TG</pubmed_authors><pubmed_authors>Holahan M</pubmed_authors><pubmed_authors>Leone JF</pubmed_authors><pubmed_authors>Chen TB</pubmed_authors><pubmed_authors>Madeira M</pubmed_authors><pubmed_authors>Mandala S</pubmed_authors><pubmed_authors>Shiao LL</pubmed_authors><pubmed_authors>Bakshi R</pubmed_authors><pubmed_authors>Xu L</pubmed_authors><pubmed_authors>Chang L</pubmed_authors><pubmed_authors>Zeng Z</pubmed_authors><pubmed_authors>O'Malley S</pubmed_authors><pubmed_authors>Rosenbach M</pubmed_authors><pubmed_authors>Joshi A</pubmed_authors><pubmed_authors>Terebetski JL</pubmed_authors><pubmed_authors>Chobanian H</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Cook J</pubmed_authors><pubmed_authors>Purcell M</pubmed_authors><pubmed_authors>Chioda M</pubmed_authors><pubmed_authors>Lin LS</pubmed_authors><pubmed_authors>Hong Q</pubmed_authors><pubmed_authors>Hargreaves R</pubmed_authors><pubmed_authors>Sullivan KA</pubmed_authors><pubmed_authors>Dellureficio J</pubmed_authors><pubmed_authors>Hajdu R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase.</name><description>We report herein the discovery of a fatty acid amide hydrolase (FAAH) positron emission tomography (PET) tracer. Starting from a pyrazole lead, medicinal chemistry efforts directed toward reducing lipophilicity led to the synthesis of a series of imidazole analogues. Compound 6 was chosen for further profiling due to its appropriate physical chemical properties and excellent FAAH inhibition potency across species. [(11)C]-6 (MK-3168) exhibited good brain uptake and FAAH-specific signal in rhesus monkeys and is a suitable PET tracer for imaging FAAH in the brain.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Jun</publication><modification>2025-04-22T17:36:50.594Z</modification><creation>2019-03-27T01:28:32Z</creation></dates><accession>S-EPMC4027136</accession><cross_references><pubmed>24900701</pubmed><doi>10.1021/ml4000996</doi></cross_references></HashMap>